Mattia A. Mahmoud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mattia A. Mahmoud has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Carla R. Zeballos Torrez
Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3 shared publications- Anne Marie McCarthy
University of Pennsylvania 3 Department of Biostatistics, Epidemiology, and Informatics Philadelphia, Pennsylvania
2 shared publications - Christine E. Edmonds
Department of Radiology, Hospital of the University of Pennsylvania , Philadelphia, PA
2 shared publications - Oluwadamilola Motunaryo Md Fayanju
Abramson Cancer Center, Penn Medicine, Philadelphia, PA
2 shared publications Alex Nguyen
Department of Radiology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA
1 shared publicationAnne Marie McCarthy
Department of Biostatistics, Epidemiology, & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA; Abramson Cancer Center, Penn Medicine, Philadelphia, PA
1 shared publication
Latest Publications
- 1 January 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (1) , e251041
Black-White Racial Differences in Background Parenchymal Enhancement at Breast MRI
Black women had higher levels of background parenchymal enhancement at breast MRI than White women, despite their lower Breast Imaging Reporting and Data System breast density.
- 1 January 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (1) , e251041
Black-White Racial Differences in Background Parenchymal Enhancement at Breast MRI
Black women had higher levels of background parenchymal enhancement at breast MRI than White women, despite their lower Breast Imaging Reporting and Data System breast density.
- Open Access
Racial differences in quantitative background parenchymal enhancement on breast magnetic resonance imaging
Importance: Although Black women have higher absolute quantitative breast density, they are often assigned lower subjectively determined Breast Imaging and Reporting Data System (BI‐RADS) density scores than White women. Background parenchymal enhancement (BPE) on breast magnetic resonance imaging is independently linked to breast cancer risk and may improve risk stratification for Black and White women. Objective: To evaluate differences in quantitative BPE between Black and White women and determine whether breast cancer risk factors mediate these differences. Design, Setting, and Participants: A cross‐sectional study of 1202 women (200 Black, 1002 White; aged 40–74 years) with negative mammograms and no breast cancer history who underwent breast magnetic resonance imaging between 2016 and 2023 at an academic medical center. Exposures: Self‐reported race (Black vs. White). Main Outcomes and Measures: The primary outcome was automated, quantitative BPE (median BPE and BPE ratio). Covariates included BI‐RADS density, fibroglandular tissue volume, qualitative BPE, age, body mass index, and menopausal status. Results: Fewer Black women were classified as having extremely dense breasts (10% vs. 21%; p < .01), yet similar proportions had high qualitative BPE (35% vs. 29%; p = .29). Quantitative BPE was significantly higher in Black women (median difference, 1.51; standard deviation, 9; 95% CI, 0.13–2.90), independent of covariates. No risk factors mediated this difference. Conclusions and Relevance: Despite lower BI‐RADS density in Black women, as suggested by prior literature, higher quantitative BPE was found, suggesting that BPE captures aspects of breast tissue composition not reflected by density. Future studies can incorporate BPE into risk models, which can improve performance and reduce disparities in risk prediction.
Open AccessRacial differences in quantitative background parenchymal enhancement on breast magnetic resonance imaging
Importance: Although Black women have higher absolute quantitative breast density, they are often assigned lower subjectively determined Breast Imaging and Reporting Data System (BI‐RADS) density scores than White women. Background parenchymal enhancement (BPE) on breast magnetic resonance imaging is independently linked to breast cancer risk and may improve risk stratification for Black and White women. Objective: To evaluate differences in quantitative BPE between Black and White women and determine whether breast cancer risk factors mediate these differences. Design, Setting, and Participants: A cross‐sectional study of 1202 women (200 Black, 1002 White; aged 40–74 years) with negative mammograms and no breast cancer history who underwent breast magnetic resonance imaging between 2016 and 2023 at an academic medical center. Exposures: Self‐reported race (Black vs. White). Main Outcomes and Measures: The primary outcome was automated, quantitative BPE (median BPE and BPE ratio). Covariates included BI‐RADS density, fibroglandular tissue volume, qualitative BPE, age, body mass index, and menopausal status. Results: Fewer Black women were classified as having extremely dense breasts (10% vs. 21%; p < .01), yet similar proportions had high qualitative BPE (35% vs. 29%; p = .29). Quantitative BPE was significantly higher in Black women (median difference, 1.51; standard deviation, 9; 95% CI, 0.13–2.90), independent of covariates. No risk factors mediated this difference. Conclusions and Relevance: Despite lower BI‐RADS density in Black women, as suggested by prior literature, higher quantitative BPE was found, suggesting that BPE captures aspects of breast tissue composition not reflected by density. Future studies can incorporate BPE into risk models, which can improve performance and reduce disparities in risk prediction.
- Open Access
- 15 July 2025
- Published by Elsevier in Clinical Breast Cancer
- Vol. 26 (1) , 187-194
Exploring Imaging Biomarkers to Improve Equity in Supplemental and High-Risk Breast Cancer Screening Between Black and White Women: A Perspective on Background Parenchymal Enhancement and Breast Density
- 15 July 2025
- Published by Elsevier in Clinical Breast Cancer
- Vol. 26 (1) , 187-194
Open AccessExploring Imaging Biomarkers to Improve Equity in Supplemental and High-Risk Breast Cancer Screening Between Black and White Women: A Perspective on Background Parenchymal Enhancement and Breast Density
- Open Access
Galectin-3 is Associated with Heart Failure Incidence: A Meta-Analysis
Introduction Heart failure (HF) is a leading cause of death worldwide. The global prevalence of heart failure is projected to increase rapidly in the coming decades, and significant attention has turned to improving biomarker-based risk prediction of incident HF. The aim of this paper was to qualitatively and quantitatively evaluate the evidence associating levels of galectin-3 with risk of incident HF. Methods A review of PUBMED-indexed peer-reviewed literature was performed. Nine studies met inclusion criteria, and all nine had data eligible for conversion and pooling. A random-effects meta-analysis was performed using hazard ratios and 95% confidence intervals from a minimally adjusted model, a further adjusted model, and from subgroups within the further-adjusted model. Results The minimally-adjusted model provided a HR of 1.97 (95% CI 1.74-2.23) when comparing the top quartile of log-gal-3 to the bottom quartile. The further-adjusted model provided a HR of 1.32 (95% CI 1.21-1.44) for the same comparison. The positive, significant association was conserved during sensitivity analysis. Conclusion There is a significant positive association between levels of circulating galectin-3 and risk of incident heart failure. Given the complex mechanistic relationship between galectin-3 and cardiovascular pathophysiology, further investigation is recommended for possible implementation of galectin-3 into clinical risk prediction models.
Open AccessGalectin-3 is Associated with Heart Failure Incidence: A Meta-Analysis
Introduction Heart failure (HF) is a leading cause of death worldwide. The global prevalence of heart failure is projected to increase rapidly in the coming decades, and significant attention has turned to improving biomarker-based risk prediction of incident HF. The aim of this paper was to qualitatively and quantitatively evaluate the evidence associating levels of galectin-3 with risk of incident HF. Methods A review of PUBMED-indexed peer-reviewed literature was performed. Nine studies met inclusion criteria, and all nine had data eligible for conversion and pooling. A random-effects meta-analysis was performed using hazard ratios and 95% confidence intervals from a minimally adjusted model, a further adjusted model, and from subgroups within the further-adjusted model. Results The minimally-adjusted model provided a HR of 1.97 (95% CI 1.74-2.23) when comparing the top quartile of log-gal-3 to the bottom quartile. The further-adjusted model provided a HR of 1.32 (95% CI 1.21-1.44) for the same comparison. The positive, significant association was conserved during sensitivity analysis. Conclusion There is a significant positive association between levels of circulating galectin-3 and risk of incident heart failure. Given the complex mechanistic relationship between galectin-3 and cardiovascular pathophysiology, further investigation is recommended for possible implementation of galectin-3 into clinical risk prediction models.